1. SUMOylation of FOXM1B Alters Its Transcriptional Activity on Regulation of MiR-200 Family and JNK1 in MCF7 Human Breast Cancer Cells
   Chiung-Min Wang et al, 2014, International Journal of Molecular Sciences CrossRef
2. Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation
   Jun Liu et al, 2016, Oncotarget CrossRef
3. SUMO conjugation – a mechanistic view
   Andrea Pichler et al, 2017, Biomolecular Concepts CrossRef
4. Jun Dimerization Protein 2 Activates Mc2r Transcriptional Activity: Role of Phosphorylation and SUMOylation
   Chiung-Min Wang et al, 2017, International Journal of Molecular Sciences CrossRef
5. Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibitingNF-κBgene transcription
   Wei Wu et al, 2016, World Journal of Hepatology CrossRef
6. Increased Small Ubiquitin-like Modifier-Activating Enzyme SAE1 Promotes Hepatocellular Carcinoma by Enhancing mTOR SUMOylation
   Yuwei Chen et al, 2023, Laboratory Investigation CrossRef
7. Abnormal protein SUMOylation in liver disease: novel target for therapy
   Yanfang Yang et al, 2024, Journal of Molecular Medicine CrossRef
8. Epigenetic remodelling in human hepatocellular carcinoma
   Maria Rita Braghini et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
9. Down-regulation of UBC9 increases the sensitivity of hepatocellular carcinoma to doxorubicin
   Sufen Fang et al, 2017, Oncotarget CrossRef
10. SUMOylation of large tumor suppressor 1 at Lys751 attenuates its kinase activity and tumor-suppressor functions
    Liu Mei et al, 2017, Cancer Letters CrossRef
11. Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma
    Jun Liu et al, 2015, BMC Cancer CrossRef
12. Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer
    Xiaoke Liu et al, 2015, Journal of Hematology & Oncology CrossRef
13. Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer
    P. S. Thakur et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
14. Protein SUMOylation modification and its associations with disease
    Yanfang Yang et al, 2017, Open Biology CrossRef
15. Regulation of post-translational modification in breast cancer treatment
    Kyung-Sun Heo, 2019, BMB Reports CrossRef
16. miR‑122/SENP1 axis confers stemness and chemoresistance to liver cancer through Wnt/β‑catenin signaling
    Jianbo Dai et al, 2023, Oncology Letters CrossRef
17. Sumoylation in liver disease
    Min Zeng et al, 2020, Clinica Chimica Acta CrossRef
18. The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development
    Hongchao Yuan et al, 2021, Cancers CrossRef
19. Emerging role of SENP1 in tumorigenesis and cancer therapy
    Min Lin et al, 2024, Frontiers in Pharmacology CrossRef
20. The role of SUMOylation in the neurovascular dysfunction after acquired brain injury
    Pengren Luo et al, 2023, Frontiers in Pharmacology CrossRef
21. Branching and Mixing: New Signals of the Ubiquitin Signaling System
    Daniel Perez-Hernandez et al, 2020, Ubiquitin - Proteasome Pathway CrossRef
22. SENP1 participates in Irinotecan resistance in human colon cancer cells
    Ming‐Cheng Chen et al, 2021, Journal of Cellular Biochemistry CrossRef
23. Knockdown of Uba2 inhibits colorectal cancer cell invasion and migration through downregulation of the Wnt/β‐catenin signaling pathway
    Hongjing Cheng et al, 2018, Journal of Cellular Biochemistry CrossRef
24. SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma
    Wenwen Zhang et al, 2016, Tumor Biology CrossRef
25. FOXP3 Activates SUMO-Conjugating UBC9 Gene in MCF7 Breast Cancer Cells
    Chiung-Min Wang et al, 2018, International Journal of Molecular Sciences CrossRef